Clinical Trials Browser

regorafenib × Other hematologic neoplasm × 1 year × Clear all

NCT03042689 2026-01-08

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06454409 2025-11-19

Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Suspended

MyeloidOther hematologic neoplasm

GATA2 Deficiency, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute